Beta Bionics, Inc. (BBNX) earnings date
Mar 9, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 10% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 29 days, typically, give or take 20 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Tue, Oct 27, 2026 | after close | 27 | 8-K |
| Q2 FY2026 | Wed, Jul 29, 2026 | after close | 29 | 8-K |
| Q1 FY2026 | Tue, Apr 21, 2026 | after close | 21 | 8-K |
| Q4 FY2025 | Tue, Feb 17, 2026 | after close | 48 | 8-K |
| Q3 FY2025 | Tue, Oct 28, 2025 | after close | 28 | 8-K |
| Q2 FY2025 | Tue, Jul 29, 2025 | after close | 29 | 8-K |
| Q1 FY2025 | Tue, May 6, 2025 | after close | 36 | 8-K |
| Q4 FY2024 | Tue, Mar 25, 2025 | after close | 84 | 8-K |
What they guided beta
| Q3 FY2026 | "EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance IRVINE, Calif., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended September 30, 2026 and updated its full year guidance for the year ending December 31, 2026." exhibit |
| Q3 FY2026 | "The Company expects to commercialize 3D Intelligence in the United States as iLet 3D™ and Mint 3D™ in the first half of 2027, with the potential for an earlier launch in the fourth quarter of 2026, subject to regulatory clearance by the FDA." exhibit |
| Q3 FY2026 | "Commercial launch of the integrated iLet and Eversense 365 system expected in the fourth quarter of 2026." exhibit |
| Q3 FY2026 | "2026 Full Year Guidance Estimated total revenue of approximately $124 million to $126 million (previously $121 million to $126 million)." exhibit |
| Q3 FY2026 | "Revenue guidance reflects a potential revenue deferral impact of up to $8.5 million in the fourth quarter of 2026 as new prospective iLet users could choose to await the launch of Mint." exhibit |
| Q2 FY2026 | "EX-99.1 2 exh_991.htm PRESS RELEASE EdgarFiling EXHIBIT 99.1 Beta Bionics Announces Second Quarter 2026 Financial Results and Updates Full Year 2026 Guidance IRVINE, Calif., July 29, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results for the quarter ended June 30, 2026 and updated its full year guidance for the year ending December 31, 2026." exhibit |
| Q2 FY2026 | "Recent Strategic Highlights In July, initiated enrollment for a pivotal trial studying the iLet in adults with type 2 diabetes in the U.S. Beta Bionics expects to expand iLet’s indications for use to adults with type 2 diabetes in the U.S. around mid-year 2027, subject to regulatory clearance by the FDA." exhibit |
| Q2 FY2026 | "In its most recent Phase 2a feasibility trial in New Zealand initiated in the first quarter of 2026 for the bihormonal system in development, the company identified opportunities to improve the glucagon asset’s excipient profile and the bihormonal dosing algorithm, with improvements expected to take less than one year prior to initiating additional feasibility trials. 2026 Full Year Guidance Estimated total revenue of approximately $131 million to $136 million (no change versus previous guidance)." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/BBNX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/BBNX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/BBNX/"><img src="https://veritasdata.dev/embed/BBNX.svg" alt="BBNX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/BBNX/)
Script
<script async src="https://veritasdata.dev/embed/BBNX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/BBNX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.